Steven Brem, MD | |
3400 Spruce Street, 3 Silverstein Building, Philadelphia, PA 19104-4206 | |
(215) 662-3487 | |
(813) 745-3510 |
Full Name | Steven Brem |
---|---|
Gender | Male |
Speciality | Neurological Surgery |
Location | 3400 Spruce Street, Philadelphia, Pennsylvania |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538195854 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | MD444179 (Pennsylvania) | Primary |
Entity Name | University Of Penn - Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235527342 PECOS PAC ID: 6204730955 Enrollment ID: O20141111000091 |
News Archive
In a randomized trial that included nearly 15,000 male physicians, long-term daily multivitamin use resulted in a modest but statistically significant reduction in cancer after more than a decade of treatment and follow-up, according to a study appearing in JAMA.
New findings in breast cancer research by an international team of scientists contradict the prevailing belief that only basal-like cells with stem cell qualities can form invasive tumors. Research led by Ole William Petersen at the University of Copenhagen (CU) and Mina Bissell of the Lawrence Berkeley National Laboratory (Berkeley Lab) and has shown that luminal-like cells with no detectable stem cell qualities can generate larger tumors than their basal-like counterparts.
Savient Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved KRYSTEXXA™ (pegloticase), a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated.
Who has overcome an infection with the virus without noticing, and how many people have already produced protective antibodies against the new coronavirus? Various antibody studies are now under way that will provide information on immunity or seroprevalence in the population.
Researchers analyzed 2,000 viral genomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the causative agent of coronavirus disease 2019 (COVID-19) – sequences obtained from India and found a new variant that could be more infectious and transmissible.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Steven Brem, MD 3400 Spruce Street, 3 Silverstein Building, Philadelphia, PA 19104-4206 Ph: (215) 662-3487 | Steven Brem, MD 3400 Spruce Street, 3 Silverstein Building, Philadelphia, PA 19104-4206 Ph: (215) 662-3487 |
News Archive
In a randomized trial that included nearly 15,000 male physicians, long-term daily multivitamin use resulted in a modest but statistically significant reduction in cancer after more than a decade of treatment and follow-up, according to a study appearing in JAMA.
New findings in breast cancer research by an international team of scientists contradict the prevailing belief that only basal-like cells with stem cell qualities can form invasive tumors. Research led by Ole William Petersen at the University of Copenhagen (CU) and Mina Bissell of the Lawrence Berkeley National Laboratory (Berkeley Lab) and has shown that luminal-like cells with no detectable stem cell qualities can generate larger tumors than their basal-like counterparts.
Savient Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved KRYSTEXXA™ (pegloticase), a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated.
Who has overcome an infection with the virus without noticing, and how many people have already produced protective antibodies against the new coronavirus? Various antibody studies are now under way that will provide information on immunity or seroprevalence in the population.
Researchers analyzed 2,000 viral genomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the causative agent of coronavirus disease 2019 (COVID-19) – sequences obtained from India and found a new variant that could be more infectious and transmissible.
› Verified 2 days ago
Xun Li, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 800 Spruce St, Philadelphia, PA 19107 Phone: 215-316-5151 | |
Dr. Ahmet Fatih Atik, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Cotton St, Philadelphia, PA 19127 Phone: 215-892-7600 | |
Richard Schmidt, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 909 Walnut St Fl 2, Philadelphia, PA 19107 Phone: 215-955-7000 Fax: 215-503-7038 | |
Dr. Srinivasa Prasad Venkata Kanuparthi, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3401 N Broad St, Philadelphia, PA 19140 Phone: 215-707-7200 Fax: 215-707-3831 | |
John Y Lee, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce Street, 3 Silverstein Bldg, Philadelphia, PA 19104 Phone: 215-662-3487 | |
Dr. Nduka Mgbechinyere Amankulor, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3400 Civic Center Blvd, 2nd Flr South Pavilion, Philadelphia, PA 19104 Phone: 215-662-3487 Fax: 215-349-5534 | |
Kareem Amir Zaghloul, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 3400 Spruce St, 1 Maloney Building, Philadelphia, PA 19104 Phone: 215-662-3957 |